Brief: Xbrane Biopharma Q3 EBITDA SEK -28.9 Million

Xbrane Biopharma AB

24/10/2024 07:00

Oct 24 (Reuters) - Xbrane Biopharma Q3 EPS SEK -0.03.
* Q3 revenue SEK 66.8 million
* Q3 net income SEK -45.1 million